Best treatment option for infantile chronic myeloid leukemia patients: imatinib or hematopoietic stem cell transplantation?
Department of Pediatrics, Pediatric Hematology-Oncology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey. arzuakcay@yahoo.com.
Arzu
A
Akcay
Deniz
D
Tugcu
Gonul
G
Aydogan
Fatih
F
Erbey
Zafer
Z
Salcioglu
Ferhan
F
Akici
Gulyuz
G
Ozturk
D001549:Benzamides / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D007223:Infant; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate